<code id='3064239A13'></code><style id='3064239A13'></style>
    • <acronym id='3064239A13'></acronym>
      <center id='3064239A13'><center id='3064239A13'><tfoot id='3064239A13'></tfoot></center><abbr id='3064239A13'><dir id='3064239A13'><tfoot id='3064239A13'></tfoot><noframes id='3064239A13'>

    • <optgroup id='3064239A13'><strike id='3064239A13'><sup id='3064239A13'></sup></strike><code id='3064239A13'></code></optgroup>
        1. <b id='3064239A13'><label id='3064239A13'><select id='3064239A13'><dt id='3064239A13'><span id='3064239A13'></span></dt></select></label></b><u id='3064239A13'></u>
          <i id='3064239A13'><strike id='3064239A13'><tt id='3064239A13'><pre id='3064239A13'></pre></tt></strike></i>

          hotspot

          hotspot

          author:comprehensive    Page View:6
          Limor Appelbaum, radiation oncologist and a researcher working on the effort to predict pancreatic cancer for early detection, using AI analysis of vast amounts of electronic health records. -- health coverage from STAT
          Suzanne Kreiter/Globe staff

          Limor Appelbaum has seen too many patients whose first sign of a fatal illness came too late.

          Often it’s yellowed eyes from jaundice, caused by a cancerous tumor on the pancreas that has grown so large it presses against the bile duct system. By this point, little can be done. “All we can really offer them is something that can prolong life by a few months,” and comfort care, said Appelbaum, a staff scientist at Beth Israel Deaconess Medical Center.

          advertisement

          Only 11 percent of people diagnosed with pancreatic cancer are alive five years later.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more
          NIH director takes cautious approach to Biden drug pricing priority
          NIH director takes cautious approach to Biden drug pricing priority

          NIHDirectorMonicaBertagnolliKevinDietsch/GettyImagesWASHINGTON—PresidentBidenhaspromisedtorequirefai

          read more
          State Dept. review finds Biden bears some blame for Afghanistan failures
          State Dept. review finds Biden bears some blame for Afghanistan failures

          3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

          read more

          Why patients can’t get everything they want on drug pricing

          AdobeYoudon’thavetobeaneconomisttounderstandthelawofdemand:Thehighertheprice,thelesslikelyacustomeri